about
Red herring in returned traveler: drug reaction with eosinophilia and systemic symptom (DRESS) syndrome mimicking sepsis.Venous thromboembolism management in Northeast Melbourne - How does it compare to international guidelines and data?Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events.Retrospective review on isolated distal deep vein thrombosis (IDDVT) - A benign entity or not?Use of computed tomography abdomen and pelvis for investigation of febrile neutropenia in adult haematology patients.Retrospective evaluation of venous thromboembolism: Are all transient provoking events the same?Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients.Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism.Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population.A comparison of global coagulation assays between normal controls and patients with thrombocytopeniaPeripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myelomaLow vision services provided by optometrists in Victoria, AustraliaAn evaluation of global coagulation assays in myeloproliferative neoplasmMaximising yield of peripheral blood flow cytometry for chronic lymphoproliferative disordersSuperficial venous thrombosis: is it as benign as we think?Real-World Direct Oral Anticoagulants Experience in Atrial Fibrillation: Falls Risk and Low Dose Anticoagulation are Predictive of both Bleeding and Stroke RiskGlobal coagulation assays in patients with multiple myeloma and monoclonal gammopathy of unknown significanceA review of global coagulation assays - Is there a role in thrombosis risk prediction?
P50
Q33418396-B5392F16-BCF9-4428-AF90-AE4A48C35D81Q36411009-913F9FE8-DC42-4C5F-9F06-B536E5003C89Q38809945-BEB66FF9-036F-4DCA-9B68-3178F7607292Q38811854-8B91824D-944C-49DB-9C46-EA0086F5F4DBQ40081185-9AD45BBB-F62D-4A80-823D-0B5979909927Q40286754-4299103E-6B38-48C0-AEE2-2DCEB8548197Q40758750-2D83487F-DB6E-4744-BFB9-DB2C2CEBD03CQ52646538-EEB78214-5FE4-4547-B2EE-110203CCC8FDQ55050376-9520AF47-612B-4815-9ED9-FE27DBF88194Q58543462-EE7EB713-F19E-4D68-BD9B-31311DFDE9CFQ59243045-8A7E093D-4C1F-45C2-803A-B53376452BE0Q80692057-E93DB874-7CE8-445B-841D-D0CE1D637A2AQ88051908-1139805A-0E93-42A6-A420-98326E74517EQ88782172-E63162FE-3EE7-497F-8B30-C3B68B3ECB74Q89706321-A635F706-FFA9-4A5C-8FEE-AFA8779DBFAEQ90366291-DB0328EE-57BE-49E6-95D8-9336E8AD7CF6Q91028154-5ED3B3E6-6690-4340-BB68-5CBDC9F3FE25Q91945024-DAC9FC77-173A-4581-A447-7674966D6A0A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hui Yin Lim
@ast
Hui Yin Lim
@en
Hui Yin Lim
@es
Hui Yin Lim
@nl
Hui Yin Lim
@sl
type
label
Hui Yin Lim
@ast
Hui Yin Lim
@en
Hui Yin Lim
@es
Hui Yin Lim
@nl
Hui Yin Lim
@sl
prefLabel
Hui Yin Lim
@ast
Hui Yin Lim
@en
Hui Yin Lim
@es
Hui Yin Lim
@nl
Hui Yin Lim
@sl
P106
P108
P31
P496
0000-0003-2455-3155